Literature DB >> 10534010

Effect of longeing and glucosamine supplementation on serum markers of bone and joint metabolism in yearling quarter horses.

J I Fenton1, M W Orth, K A Chlebek-Brown, B D Nielsen, C D Corn, K S Waite, J P Caron.   

Abstract

The effect of longeing and glucosamine supplementation on known biological markers of joint disease was studied in yearling quarter horses. Twenty-one yearling quarter horses were randomly assigned to one of 4 treatments: 1) longeing (longeing 20 min daily) supplement control (LN); 2) longeing/glucosamine (LG); 3) walking (mechanical walker for 120 min daily (WN)); and 4) walking/glucosamine (WG). Oral glucosamine was administered at 5.5 g b.i.d. weeks 1-4, 3.5 g b.i.d. during weeks 5-6, and 2.0 g b.i.d. during weeks 7-8. Serum was obtained weekly for 8 wk and analyzed for keratan sulfate and osteocalcin concentrations. Walked horses receiving glucosamine showed slight elevation in serum keratan sulfate compared to controls (P = 0.04). Glucosamine or longeing exercise had no significant effect (6 > or = 0.08) on serum osteocalcin concentrations. Under these conditions, longeing and/or glucosamine supplementation did not significantly alter serum concentrations of keratan sulfate or osteocalcin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10534010      PMCID: PMC1189567     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  8 in total

1.  Evaluation of the catabolic activity of cartilage by measurement of serum keratan sulfate concentration in foals.

Authors:  M Okumura; T Fujinaga; E Urakawa; M Tagami; K Tsukiyama
Journal:  Am J Vet Res       Date:  1997-08       Impact factor: 1.156

2.  Increase in levels of serum keratan sulfate following cartilage proteoglycan degradation in the rabbit knee joint.

Authors:  J M Williams; C Downey; E J Thonar
Journal:  Arthritis Rheum       Date:  1988-04

3.  Serum osteocalcin or bone Gla-protein, a biochemical marker for bone metabolism in horses: differences in serum levels with age.

Authors:  O M Lepage; M Marcoux; A Tremblay
Journal:  Can J Vet Res       Date:  1990-04       Impact factor: 1.310

4.  Keratan sulfate as a marker of articular cartilage catabolism and joint treatment in ponies.

Authors:  R J Todhunter; A E Yeager; K P Freeman; E J Parente; G Lust
Journal:  Am J Vet Res       Date:  1993-07       Impact factor: 1.156

5.  The neglect of glucosamine as a treatment for osteoarthritis--a personal perspective.

Authors:  M F McCarty
Journal:  Med Hypotheses       Date:  1994-05       Impact factor: 1.538

6.  New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.

Authors:  P A Price; J G Parthemore; L J Deftos
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

7.  Quantification of keratan sulfate in blood as a marker of cartilage catabolism.

Authors:  E J Thonar; M E Lenz; G K Klintworth; B Caterson; L M Pachman; P Glickman; R Katz; J Huff; K E Kuettner
Journal:  Arthritis Rheum       Date:  1985-12

8.  Pharmacokinetics of glucosamine in the dog and in man.

Authors:  I Setnikar; C Giacchetti; G Zanolo
Journal:  Arzneimittelforschung       Date:  1986-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.